This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Celgene Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Fadi George Towfic: Innovator in Lymphoma Classification
Introduction
Fadi George Towfic is a notable inventor based in Madison, NJ (US). He has made significant contributions to the field of oncology, particularly in the classification of diffuse large B-cell lymphoma (DLBCL). His innovative methods have the potential to improve patient outcomes through more accurate diagnoses.
Latest Patents
Fadi George Towfic holds a patent for "Methods of classifying diffuse large B-cell lymphoma." This patent describes a method for predicting whether a subject has an Activated B Cell-like (ABC) subtype or a non-ABC subtype of DLBCL. The process involves obtaining a sample from the subject, measuring the expression levels of CD10, MUM1, FOXP1, and optionally Bcl-6. A composite score is then determined based on these expression levels, which aids in predicting the subtype of DLBCL.
Career Highlights
Fadi is currently employed at Celgene Corporation, where he continues to work on innovative solutions in the field of cancer research. His expertise and dedication to improving diagnostic methods have made him a valuable asset to his team.
Collaborations
Fadi collaborates with talented colleagues, including Yixin Wang and Sarah Hersey. Their combined efforts contribute to advancing research and developing new methodologies in oncology.
Conclusion
Fadi George Towfic's work in lymphoma classification exemplifies the impact of innovation in medical research. His contributions are paving the way for improved diagnostic techniques that can enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile